Loading clinical trials...
Loading clinical trials...
Evaluation of Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Phase III, Multicenter, Randomized Trial
Conditions
Interventions
Secondary Cytoreductive Surgery
Salvage Chemotherapy
Locations
4
China
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China
Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, China
Shanghai Zhongshan Hospital
Shanghai, Shanghai Municipality, China
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Start Date
July 19, 2012
Primary Completion Date
December 1, 2019
Completion Date
December 1, 2022
Last Updated
June 10, 2021
NCT06290193
NCT06855706
NCT05271318
NCT06295965
NCT06492070
NCT05059444
Lead Sponsor
Shanghai Gynecologic Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions